ROMA scale: postmenopause
The validity period of online orders: 3 months from the purchase date.
What is this?
ROMA (Risk of Ovarian Malignancy Algorithm) is an algorithm that helps assess the risk of ovarian cancer based on two biological markers – HE4 and CA-125, and the menopausal status of the woman. This version is applied to postmenopausal women.
When is it recommended?
- Detected ovarian mass during ultrasound;
- Monitoring existing ovarian disease or aiming to detect an oncological process early;
- Planning surgical treatment.
Patient benefit:
The ROMA scale helps the doctor determine whether a woman needs specialized oncological care. This is particularly important for assessing the risk of malignant processes at early stages.
Important:
ROMA is not a diagnostic test but a risk assessment tool. If the risk is increased, further tests are recommended (e.g., CT, MRI, or laparoscopy).
0.00€
